Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome.

× No keyword cloud information.

17 in total

1. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.

Authors: Liam R Brunham; Steven Baker; Andrew Mammen; G B John Mancini; Robert S Rosenson
Journal: Cardiovasc Res Date: 2018-07-01 Impact factor: 10.787

2. Exercise-induced myalgia and rhabdomyolysis in a patient with the rare m.3243A>T mtDNA mutation.

Authors: David Czell; Angela Abicht; Jürgen Hench; Markus Weber
Journal: BMJ Case Rep Date: 2012-12-06

3. Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.

Authors: Beatrice A Golomb; Abril Verden; Alexis K Messner; Hayley J Koslik; Keith B Hoffman
Journal: Drug Saf Date: 2018-04 Impact factor: 5.606

Review 4. HMG-CoA reductase inhibitors and myotoxicity.

Authors: M Ucar; T Mjörndal; R Dahlqvist
Journal: Drug Saf Date: 2000-06 Impact factor: 5.606

Review 5. The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.

Authors: Iain P Hargreaves; Andrew J Duncan; Simon J R Heales; John M Land
Journal: Drug Saf Date: 2005 Impact factor: 5.606

6. Inhibition of in vitro metabolism of simvastatin by itraconazole in humans and prediction of in vivo drug-drug interactions.

Authors: M Ishigam; M Uchiyama; T Kondo; H Iwabuchi; S Inoue; W Takasaki; T Ikeda; T Komai; K Ito; Y Sugiyama
Journal: Pharm Res Date: 2001-05 Impact factor: 4.200

Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome.

1. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.

2. Exercise-induced myalgia and rhabdomyolysis in a patient with the rare m.3243A>T mtDNA mutation.

3. Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.

Review 4. HMG-CoA reductase inhibitors and myotoxicity.

Review 5. The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.

6. Inhibition of in vitro metabolism of simvastatin by itraconazole in humans and prediction of in vivo drug-drug interactions.

7. Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin.

Review 8. How do you treat patients with myalgia who take statins?

Review 9. Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia.

Review 10. Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.